Protocol for China endoscopic and robotic breast surgery guidelines (2026 edition)
- VernacularTitle:中国腔镜/机器人乳腺手术指南（2026版）计划书
- Author:
Zhenggui DU
1
;
Qing LÜ
1
;
Pengwei LÜ
2
;
Dajiang SONG
3
;
Zihan WANG
4
;
Benlong YANG
5
;
Shicheng SU
6
Author Information
1. Breast Disease Center of West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
2. Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China
3. Department of Oncologic Plastic Surgery, Hunan Cancer Hospital, Changsha, 410013, P. R. China
4. Department of Breast Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing, 100020, P. R. China
5. Breast Surgery Department, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China
6. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China
- Collective Name:Chinese Endoscopic-robotic Breast Surgery Clinical Trials Consortium (CErBSCTC)
- Publication Type:Journal Article
- Keywords:
Breast cancer;
endoscopic breast surgery;
robotic breast surgery;
guideline;
protocol;
test;
evidence
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2026;33(03):333-338
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer is the most common malignant tumor among women in China, with surgery being one of the primary treatment modalities. Endoscopic/robotic breast surgery (ErBS) is gaining widespread acceptance among patients and surgeons alike due to its advantages of minimal invasiveness, superior cosmetic outcomes, and accelerated recovery. However, substantial heterogeneity currently exists across China regarding patient selection, standardized operative techniques, perioperative management, and complication handling, underscoring the urgent need for evidence-based consensus guidelines. To promote standardization and ensure consistent quality of ErBS, the Chinese Endoscopic-Robotic Breast Surgery Clinical Trials Consortium (CErBSCTC) has systematically reviewed the latest high-quality evidence and formulated the "Protocol for China Endoscopic and Robotic Breast Surgery Guidelines (2026 edition)", which outlines a comprehensive methodology for guideline development.
